Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer

Overview of attention for article published in Cochrane database of systematic reviews, July 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog

twitter: 3 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,197 followers.

RT @DrJoMorrison1: Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer - Newhouse, R - 2023 | Cochrane Library well done…

10 Jul 2023

Reply Repost Favourite

Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer - Newhouse, R - 2023 | Cochrane Library well done to ⁦@NewhouseRebecca⁩ and team for a mammoth effort summarising this evidence in recurrent ovarian cancer https://t.co/ECdHFKFdKw

10 Jul 2023

Reply Repost Favourite

https://t.co/zq30QqIFhu

07 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.